Tat-NR2B9c

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Tat-NR2B9c (NA-1) is a neuroprotective agent; exhibits high-affinity binding to the second PDZ domain of PSD-95.

Tat-NR2B9c (NA-1) is a neuroprotective agent; exhibits high-affinity binding to the second PDZ domain of PSD-95; inhibits NR2A-NR2C/PSD-95 interactions (IC50=1-10 uM) and nNOS/PSD-95 interaction (IC50=200 nM).Stroke Phase 3 Clinical

NA-1

Others

Other Targets

Other Targets

Neurological Disease

Stroke

500992-11-0

2518.88

C105H188N42O30

>98% (HPLC)

H2O

CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C(CC1=CC=C(C=C1)O)N

L-Valine, L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-seryl-L-seryl-L-isoleucyl-L-α-glutamyl-L-seryl-L-α-aspartyl-

(-20℃)

With Ice Pack

≥ 2 years